Literature DB >> 17625229

Immunolocalization of sibling and RUNX2 proteins during vertical distraction osteogenesis in the human mandible.

Lisa R Amir1, Andreas Jovanovic, Frits B T Perdijk, Satoru Toyosawa, Vincent Everts, Antonius L J J Bronckers.   

Abstract

We tested the hypothesis that mechanical loading of human bone increases expression of the transcription factor RUNX2 and bone matrix proteins osteopontin (OPN), bone sialoprotein (BSP), dentin matrix protein-1 (DMP1), and matrix extracellular phosphoglycoprotein (MEPE). We examined this in tissue sections of atrophic mandibular bone taken from edentulous patients who had undergone distraction osteogenesis. In undistracted bone, weak to moderate staining for OPN and BSP was found in osteoblasts and bone matrix of immature woven bone. RUNX2 was also detectable in osteoblasts and in cells of the periosteum. In woven bone, but not in lamellar bone, a small number of osteocytes stained for all proteins tested. After distraction, staining intensity had increased in the existing old bone and staining was seen in more bone cells than before distraction. We also found a high expression of DMP1 and MEPE in many osteocytes embedded in woven bone and in some osteocytes of lamellar bone not seen before distraction. New bone trabeculae were forming in the fibrous tissue of the distraction gap containing all stages of intramembranous bone formation. Moderate to strong staining was seen for all five proteins tested in osteocytes located in woven bone of these trabeculae and for RUNX2, OPN, and BSP in osteoblasts lining the trabecular surfaces. We conclude that loading of atrophic human jawbone by distraction activates matrix synthesis of bone cells in and around existing bone. Increased staining of DMP1 and MEPE in osteocytes after loading is in line with the concept that these proteins may be involved in signaling the effector cells to adapt the bone structure to its mechanical demands.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625229      PMCID: PMC3957525          DOI: 10.1369/jhc.6A7162.2007

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  48 in total

1.  Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts.

Authors:  S Toyosawa; S Shintani; T Fujiwara; T Ooshima; A Sato; N Ijuhin; T Komori
Journal:  J Bone Miner Res       Date:  2001-11       Impact factor: 6.741

2.  Dual functional roles of dentin matrix protein 1. Implications in biomineralization and gene transcription by activation of intracellular Ca2+ store.

Authors:  Karthikeyan Narayanan; Amsaveni Ramachandran; Jianjun Hao; Gen He; Kyle Won Park; Michael Cho; Anne George
Journal:  J Biol Chem       Date:  2003-03-03       Impact factor: 5.157

3.  The Dentin matrix protein 1 (Dmp1) is specifically expressed in mineralized, but not soft, tissues during development.

Authors:  J Q Feng; H Huang; Y Lu; L Ye; Y Xie; T W Tsutsui; T Kunieda; T Castranio; G Scott; L B Bonewald; Y Mishina
Journal:  J Dent Res       Date:  2003-10       Impact factor: 6.116

4.  Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo.

Authors:  Jelica Gluhak-Heinrich; Ling Ye; Lynda F Bonewald; Jian Q Feng; Mary MacDougall; Stephen E Harris; Dubravko Pavlin
Journal:  J Bone Miner Res       Date:  2003-05       Impact factor: 6.741

5.  Expression of dentin matrix protein 1 in tumors causing oncogenic osteomalacia.

Authors:  Satoru Toyosawa; Yasuhiko Tomita; Mitsunobu Kishino; Jun Hashimoto; Takafumi Ueda; Takahiro Tsujimura; Katsuyuki Aozasa; Naokuni Ijuhin; Toshihisa Komori
Journal:  Mod Pathol       Date:  2004-05       Impact factor: 7.842

6.  Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone.

Authors:  A L Boskey; L Spevak; E Paschalis; S B Doty; M D McKee
Journal:  Calcif Tissue Int       Date:  2002-06-20       Impact factor: 4.333

7.  Transcription and immunolocalization of Runx2/Cbfa1/Pebp2alphaA in developing rodent and human craniofacial tissues: further evidence suggesting osteoclasts phagocytose osteocytes.

Authors:  Antonius L J J Bronckers; Kenichi Sasaguri; Marten A Engelse
Journal:  Microsc Res Tech       Date:  2003-08-15       Impact factor: 2.769

8.  In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions.

Authors:  Philippe H Tartaix; Marie Doulaverakis; Anne George; Larry W Fisher; William T Butler; Chunlin Qin; Erdjan Salih; Melin Tan; Yukiji Fujimoto; Lyudmila Spevak; Adele L Boskey
Journal:  J Biol Chem       Date:  2004-02-09       Impact factor: 5.157

9.  mRNA expression and protein localization of dentin matrix protein 1 during dental root formation.

Authors:  S Toyosawa; K Okabayashi; T Komori; N Ijuhin
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

10.  MEPE has the properties of an osteoblastic phosphatonin and minhibin.

Authors:  P S N Rowe; Y Kumagai; G Gutierrez; I R Garrett; R Blacher; D Rosen; J Cundy; S Navvab; D Chen; M K Drezner; L D Quarles; G R Mundy
Journal:  Bone       Date:  2004-02       Impact factor: 4.398

View more
  14 in total

Review 1.  Bone regeneration during distraction osteogenesis.

Authors:  Lisa R Amir; Vincent Everts; Antonius L J J Bronckers
Journal:  Odontology       Date:  2009-07-29       Impact factor: 2.634

2.  Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein.

Authors:  Jennifer Forsprecher; Zhemeng Wang; Harvey A Goldberg; Mari T Kaartinen
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

3.  Epigenetic influence of KAT6B and HDAC4 in the development of skeletal malocclusion.

Authors:  Ahrin Huh; Michael J Horton; Karen T Cuenco; Gwenael Raoul; Anthea M Rowlerson; Joel Ferri; James J Sciote
Journal:  Am J Orthod Dentofacial Orthop       Date:  2013-10       Impact factor: 2.650

Review 4.  Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.

Authors:  Peter S N Rowe
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2012       Impact factor: 1.807

5.  Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.

Authors:  Anthony Martin; Jian Xiong; Theodora Koromila; Jie S Ji; Stephanie Chang; Yae S Song; Jonathan L Miller; Chun-Ya Han; Paul Kostenuik; Susan A Krum; Nyam-Osor Chimge; Yankel Gabet; Baruch Frenkel
Journal:  Bone       Date:  2015-02-17       Impact factor: 4.398

6.  The progressive ankylosis protein regulates cementum apposition and extracellular matrix composition.

Authors:  B L Foster; K J Nagatomo; S O Bamashmous; K A Tompkins; H Fong; D Dunn; E Y Chu; C Guenther; D M Kingsley; R B Rutherford; M J Somerman
Journal:  Cells Tissues Organs       Date:  2011-03-09       Impact factor: 2.481

7.  Fibroblast growth factor expression during skeletal fracture healing in mice.

Authors:  Gregory J Schmid; Chikashi Kobayashi; Linda J Sandell; David M Ornitz
Journal:  Dev Dyn       Date:  2009-03       Impact factor: 3.780

8.  Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

Authors:  Aline Martin; Valentin David; Jennifer S Laurence; Patricia M Schwarz; Eileen M Lafer; Anne-Marie Hedge; Peter S N Rowe
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

9.  Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.

Authors:  Jin-Hyung Lee; Atrayee Banerjee; Yoshi Ueno; Shashi K Ramaiah
Journal:  Toxicol Sci       Date:  2008-08-14       Impact factor: 4.849

10.  Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.

Authors:  Renata C Pereira; Harald Juppner; Carlos E Azucena-Serrano; Ora Yadin; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Bone       Date:  2009-08-11       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.